Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on vascular function and liver steatosis in diabetes

Back

ESC Professional Premium Access

Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on vascular function and liver steatosis in diabetes

Session: Diabetes and the heart (3)

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Speaker: Doctor I. Ikonomidis (Athens, GR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

5 presentations

3 followers

6 more presentations in this session

Risk of incident renal cell carcinoma in patients with type 2 diabetes on sodium-glucose co-transporter-2 inhibitor users: a population-based cohort study

Speaker: Professor G. Jong (Taichung, TW)

Fifteen-year follow-up and impact of age and sex on cardiovascular outcomes in diabetes and non-diabetes patients without CAD

Speaker: Doctor P. Thrane (Aarhus, DK)

Impact of glycated hemoglobin A1c on cardiovascular risk in diabetes patients with and without coronary artery disease

Speaker: Doctor M. Hansen (Aarhus, DK)

The impact of glycated hemoglobin A1c on cardiovascular risk in patients with and without coronary artery disease

Speaker: Doctor K. Olesen (Aarhus, DK)

Elevated remnant cholesterol in atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study

Speaker: Doctor B. Nilsson Wadstrom (Copenhagen, DK)

Access the full session

Diabetes and the heart (3)

Speakers: Doctor I. Ikonomidis, Professor G. Jong, Doctor P. Thrane, Doctor M. Hansen, Doctor K. Olesen...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on vascular function and liver steatosis in diabetes

About the speaker

Doctor Ignatios Ikonomidis

6 more presentations in this session

Risk of incident renal cell carcinoma in patients with type 2 diabetes on sodium-glucose co-transporter-2 inhibitor users: a population-based cohort study

Fifteen-year follow-up and impact of age and sex on cardiovascular outcomes in diabetes and non-diabetes patients without CAD

Impact of glycated hemoglobin A1c on cardiovascular risk in diabetes patients with and without coronary artery disease

The impact of glycated hemoglobin A1c on cardiovascular risk in patients with and without coronary artery disease

Elevated remnant cholesterol in atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study

Access the full session

Diabetes and the heart (3)

About the event

ESC Congress 2023

ESC 365 is supported by